Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-16

Clinical Trial Update: Duragen® Secure Post Marketing Clinical Follow-up (PMCF)

View source ↗

Summary

A post-marketing clinical follow-up study update for Duragen Secure related to dura mater nick/tear injuries, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duragen Secure (Duragen Secure)

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Dura Mater Nick Cut or Tear, Surgery | Status: COMPLETED | Results posted: 2018-08-16